Ad is loading...
MRKR
Price
$3.07
Change
-$0.43 (-12.29%)
Updated
Nov 15 closing price
UNCY
Price
$0.46
Change
+$0.01 (+2.22%)
Updated
Nov 15 closing price
130 days until earnings call
Ad is loading...

MRKR vs UNCY

Header iconMRKR vs UNCY Comparison
Open Charts MRKR vs UNCYBanner chart's image
Marker Therapeutics
Price$3.07
Change-$0.43 (-12.29%)
Volume$43.94K
CapitalizationN/A
Unicycive Therapeutics
Price$0.46
Change+$0.01 (+2.22%)
Volume$1.78M
CapitalizationN/A
MRKR vs UNCY Comparison Chart
Loading...
MRKR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
UNCY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
MRKR vs. UNCY commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRKR is a Sell and UNCY is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (MRKR: $3.07 vs. UNCY: $0.46)
Brand notoriety: MRKR and UNCY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MRKR: 117% vs. UNCY: 108%
Market capitalization -- MRKR: $27.39M vs. UNCY: $43.4M
MRKR [@Biotechnology] is valued at $27.39M. UNCY’s [@Biotechnology] market capitalization is $43.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRKR’s FA Score shows that 0 FA rating(s) are green whileUNCY’s FA Score has 0 green FA rating(s).

  • MRKR’s FA Score: 0 green, 5 red.
  • UNCY’s FA Score: 0 green, 5 red.
According to our system of comparison, MRKR is a better buy in the long-term than UNCY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRKR’s TA Score shows that 4 TA indicator(s) are bullish while UNCY’s TA Score has 5 bullish TA indicator(s).

  • MRKR’s TA Score: 4 bullish, 5 bearish.
  • UNCY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, UNCY is a better buy in the short-term than MRKR.

Price Growth

MRKR (@Biotechnology) experienced а -25.85% price change this week, while UNCY (@Biotechnology) price change was -22.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

MRKR is expected to report earnings on May 11, 2023.

UNCY is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UNCY($43.4M) has a higher market cap than MRKR($27.4M). MRKR YTD gains are higher at: -44.182 vs. UNCY (-46.986). MRKR has higher annual earnings (EBITDA): -10.99M vs. UNCY (-22.83M). UNCY has more cash in the bank: 41.8M vs. MRKR (7.8M). MRKR has less debt than UNCY: MRKR (0) vs UNCY (634K). MRKR (0) and UNCY (0) have equivalent revenues.
MRKRUNCYMRKR / UNCY
Capitalization27.4M43.4M63%
EBITDA-10.99M-22.83M48%
Gain YTD-44.182-46.98694%
P/E RatioN/AN/A-
Revenue00-
Total Cash7.8M41.8M19%
Total Debt0634K-
FUNDAMENTALS RATINGS
MRKR: Fundamental Ratings
MRKR
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MRKRUNCY
RSI
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
MRKR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
UNCY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANY1.490.04
+2.76%
Sphere 3D Corp
VBTX29.27-0.14
-0.48%
Veritex Holdings
NXDT5.48-0.11
-1.97%
NexPoint Diversified Real Estate Trust
ANSS332.38-7.90
-2.32%
ANSYS
RARE44.75-2.89
-6.07%
Ultragenyx Pharmaceutical

MRKR and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRKR has been loosely correlated with CGTX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MRKR jumps, then CGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRKR
1D Price
Change %
MRKR100%
-12.29%
CGTX - MRKR
36%
Loosely correlated
-9.85%
INTS - MRKR
28%
Poorly correlated
-0.79%
FATE - MRKR
27%
Poorly correlated
-2.88%
SNPX - MRKR
27%
Poorly correlated
-8.05%
UNCY - MRKR
27%
Poorly correlated
+2.68%
More

UNCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, UNCY has been loosely correlated with BLPH. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if UNCY jumps, then BLPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UNCY
1D Price
Change %
UNCY100%
+2.68%
BLPH - UNCY
35%
Loosely correlated
N/A
BBIO - UNCY
32%
Poorly correlated
-1.62%
SCPX - UNCY
28%
Poorly correlated
-8.61%
SLDB - UNCY
28%
Poorly correlated
-8.66%
MRKR - UNCY
27%
Poorly correlated
-12.29%
More